In comparison, we observed that in ordinary HCC cells with high TMEM39b expression, the inhibition of the RSL-3/GPX4 pathway was not significant, and the accumulation of peroxide remained low even after sorafenib treatment. This evidence concerns the gene GPX4 and hepatocellular carcinoma.